ASSISTANCE PROGRAMS

FOR THOSE WHO AREN’T COVERED

If you aren’t covered for the HPV vaccine, there is more than one program that may be able to help:

Vaccines for Children Program

GARDASIL 9 is part of the Vaccines for Children (VFC) Program, a federally funded program that helps provide vaccines to children whose parents or guardians may not be able to afford them. This helps ensure that all children have a better chance of getting their recommended vaccinations on schedule.

VFC gives free vaccines to children 18 or younger who:

Qualify for Medicaid

Do not have health insurance

Have health insurance that does not fully cover vaccines (these children must go to a special health clinic to get their free vaccines), or

Are American Indian or Alaskan Native

Ask your child's doctor or health care professional if he or she is a VFC enrolled provider. If he or she is not, you may be able to take your child to one of the following health clinics to get VFC vaccines:

Public health clinic (local health department)

Federally Qualified Health Center (FQHC)

Rural Health Clinic (RHC)

Contact your state’s VFC coordinator here, or call 1-800-CDC-INFO (1-800-232-4636) and ask where you should take your child to get GARDASIL 9.

Merck Vaccine Patient Assistance Program

GARDASIL 9 is part of the Merck Vaccine Patient Assistance Program (MVPAP), which is funded by Merck for adults 19 to 26 years of age who cannot afford vaccines.

This private and confidential program provides vaccines free of charge to eligible adults, primarily the uninsured who, without our assistance, could not afford needed vaccines. MVPAP offers free GARDASIL 9 to people who:

Are 19 to 26 years of age, and

Do not have health insurance, and

Cannot afford to pay for the vaccines

Visit merck.com/merckhelps for more information.

NEXT UP

 

IMPORTANT SAFETY INFORMATION

Anyone who is allergic to the ingredients of GARDASIL 9 or GARDASIL, including those severely allergic to yeast, should not receive the vaccine. GARDASIL 9 was not studied in women who knew they were pregnant.

The side effects include:

  • Pain
  • Swelling
  • Redness
  • Itching
  • Bruising
  • Bleeding
  • A lump where your child got the shot
  • Headache
  • Fever
  • Nausea
  • Dizziness
Fainting can happen after getting GARDASIL 9. Sometimes people who faint can fall and hurt themselves. For this reason, your health care professional may ask your child to sit or lie down for 15 minutes after your child gets GARDASIL 9. Some people who faint might shake or become stiff.
Only a doctor or health care professional can decide if GARDASIL 9 is right for your child.

INFORMATION ABOUT GARDASIL 9

GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and women ages 9 to 26 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by 9 types of HPV. GARDASIL 9 helps protect boys and men ages 9 to 26 against anal cancer and genital warts caused by those same HPV types.
GARDASIL 9 may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV.
GARDASIL 9 does not prevent all types of cervical cancer, so it’s important for women to continue routine cervical cancer screenings. GARDASIL 9 does not treat cancer or genital warts.
GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.
  • For persons 9 through 14 years of age, GARDASIL 9 can be given using a 2-dose or 3-dose schedule. For the 2-dose schedule, the second shot should be given 6–12 months after the first shot. If the second shot is given less than 5 months after the first shot, a third shot should be given at least 4 months after the second shot. For the 3-dose schedule, the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
  • For persons 15 through 26 years of age, GARDASIL 9 is given using a 3-dose schedule; the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
The appropriate dosing schedule will be determined by your child’s health care professional.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please read the Patient Information for GARDASIL 9 and discuss it with your child’s doctor. The physician Prescribing Information also is available.
Having trouble paying for your Merck vaccine? Merck may be able to help. Visit http://www.merck.com/merckhelps.

INFORMATION ABOUT GARDASIL 9

GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and women ages 9 to 26 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by 9 types of HPV. GARDASIL 9 helps protect boys and men ages 9 to 26 against anal cancer and genital warts caused by those same HPV types.
GARDASIL 9 may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV.
GARDASIL 9 does not prevent all types of cervical cancer, so it’s important for women to continue routine cervical cancer screenings. GARDASIL 9 does not treat cancer or genital warts.
GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.
  • For persons 9 through 14 years of age, GARDASIL 9 can be given using a 2-dose or 3-dose schedule. For the 2-dose schedule, the second shot should be given 6–12 months after the first shot. If the second shot is given less than 5 months after the first shot, a third shot should be given at least 4 months after the second shot. For the 3-dose schedule, the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
  • For persons 15 through 26 years of age, GARDASIL 9 is given using a 3-dose schedule; the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
The appropriate dosing schedule will be determined by your child’s health care professional.
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)

INFORMATION ABOUT GARDASIL 9

GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and women ages 9 to 26 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by 9 types of HPV. GARDASIL 9 helps protect boys and men ages 9 to 26 against anal cancer and genital warts caused by those same HPV types.
GARDASIL 9 may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV.
GARDASIL 9 does not prevent all types of cervical cancer, so it’s important for women to continue routine cervical cancer screenings. GARDASIL 9 does not treat cancer or genital warts.
GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.
  • For persons 9 through 14 years of age, GARDASIL 9 can be given using a 2-dose or 3-dose schedule. For the 2-dose schedule, the second shot should be given 6–12 months after the first shot. If the second shot is given less than 5 months after the first shot, a third shot should be given at least 4 months after the second shot. For the 3-dose schedule, the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
  • For persons 15 through 26 years of age, GARDASIL 9 is given using a 3-dose schedule; the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
The appropriate dosing schedule will be determined by your child’s health care professional.
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)

Please orient your device to the portrait position to return to the site.

Please orient your device to the landscape position to return to the site.